CitroTech Revenue Grows to $2.4 Million in 2025
CitroTech issued a letter to Company shareholders. "As we reflect on 2025, we are pleased to report that CitroTech is entering a new phase of growth and validation. Over the past year, we made meaningful progress advancing our mission to deliver environmentally sustainable fire inhibitor solutions while laying the foundation for scalable, long-term commercial success. Revenue grew to $2.4 million in 2025, up from $808,000 in 2024, reflecting broader adoption of our products and early-stage commercialization efforts... In December, we achieved a significant corporate milestone with the successful uplisting of CitroTech's common stock to the NYSE American. This transition reflects the progress we have made in strengthening our business, governance and financial profile, while increasing our visibility within the investment community. Our presence on a national exchange positions CitroTech to better access capital markets and support our long-term expansion...We completed a $8.1 million in Series C financing through a combination of preferred equity and convertible instruments, providing capital to accelerate commercialization, expand operations and support early-stage market adoption. Our balance sheet is stronger, and we have the financial flexibility to execute on our strategy and position CitroTech for continued growth... CitroTech continues to set the standard for fire inhibition, and in 2025, we strengthened our position as an industry leader... We continued to invest in the long-term strength of our platform by expanding our intellectual property portfolio. We now hold 37 granted patents and 45 filed or pending applications, covering core chemistry, application methods and fire inhibition technologies... We experienced encouraging adoption of our products by fire departments, particularly across California. At the same time, our wood treatment products advanced toward commercialization for the fire-retardant-treated lumber market... We also continued deploying CitroSafe Systems, proactive wildfire defense solutions for residential and commercial properties... Our focus for 2026 is execution and scale. Revenue growth is expected to accelerate as wildfire season intensifies and commercial channels expand. We are actively building partnerships across the lumber and building materials industry to increase adoption of fire-retardant-treated wood products. Deployment of CitroSafe Systems will expand beyond proof-of-concept, including deeper integration with insurance solutions. To support growth, we anticipate a measured increase in sales and general and administrative expenses as we strengthen supply chains, expand production capabilities and forge strategic partnerships. Innovation remains central, as we advance next-generation formulations and explore new applications for our technology platform. "
Trade with 70% Backtested Accuracy
Analyst Views on CITR
About CITR
About the author

- Strategic Partnership: CitroTech has formed a strategic partnership with All Terrain Fire Support Inc. to combine eco-friendly fire inhibition technology with emergency response expertise, aimed at assisting government and military agencies in wildfire prevention and asset protection, which is expected to significantly enhance market competitiveness.
- Market Opportunity: CitroTech estimates that up to 275,000 gallons of its product may be required per square mile to cover high-risk areas, highlighting the scale of protection needed and the market potential under increasingly stringent environmental standards.
- Technological Advantage: CitroTech's fire inhibition technology is recognized by the U.S. EPA's Safer Choice program and meets UL Greenguard Gold standards, ensuring superior protection while fulfilling environmental responsibilities, thus meeting the stringent requirements of government agencies.
- Expansion Plans: The partnership will initially focus on U.S. federal and military opportunities, with potential expansion across the Western United States, further solidifying CitroTech's market position in fire prevention solutions.
- Strategic Relocation: CitroTech has relocated its headquarters to Denver South, leveraging the region's innovation hub and talent pool to accelerate the global deployment of environmentally-friendly fire protection solutions, thereby enhancing its competitive edge in a rapidly growing market.
- Surging Market Demand: Colorado is one of the most wildfire-prone states in the U.S., with approximately 2.5 million residents living in high-risk areas, and CitroTech's new headquarters will enable it to respond more effectively to this urgent market demand, driving sales growth of its eco-friendly fire prevention products.
- Infrastructure Advantages: The Denver South area boasts over 48 million square feet of office space and a robust transportation network, which CitroTech will utilize to accelerate product development and market outreach, further solidifying its leadership position in the environmental fire protection sector.
- Executive Appointment: Kevin Schaff has been appointed as the new Vice President of Business Development, tasked with leading sales and marketing initiatives from the Denver office, marking an expansion of the company's leadership in the region and strengthening its ties to the local economy.
- Investor Conference Participation: CitroTech Inc. will participate in the iAccess Alpha Virtual Best Ideas Spring Investment Conference on March 10-11, 2026, where CEO Wes Bolsen will present at 1:00 PM ET on March 10, showcasing innovations in fire prevention solutions for wood products.
- One-on-One Investor Meetings: On the second day of the conference, CitroTech will engage in one-on-one meetings with pre-qualified investors, which not only helps strengthen relationships with potential investors but may also lead to new funding opportunities and market expansion.
- Eco-Friendly Fire Solutions: CitroTech is the only EPA Safer Choice recognized fire inhibitor in the U.S., focusing on manufacturing and deploying environmentally safe fire prevention solutions that meet UL Greenguard Gold standards, demonstrating its commitment to safety and environmental health.
- Long-Term Growth Potential: The company's growing patent portfolio and recurring revenue model, combined with its scalable approach, support CitroTech's long-term growth and market expansion strategy, enhancing its competitive position in the fire prevention industry.
- Strong Banking Sector Performance: Banking and savings stocks collectively rose by approximately 3.1%, indicating a renewed market confidence in the financial sector, which may attract more investor interest in this area.
- ServisFirst Bancshares Leads Gains: ServisFirst Bancshares saw its stock price increase by about 13.1%, making it one of the best performers of the day, reflecting strong market performance and positive investor sentiment.
- Dime Community Bancshares Follows Suit: Dime Community Bancshares' stock rose by approximately 12.4%, indicating significant market recognition for the company in the competitive banking industry, potentially driving its future growth prospects.
- Industry Trend Analysis: With the strong rebound in banking stocks, investors may reassess investment opportunities in the financial sector, especially against the backdrop of economic recovery, where banking profitability is expected to further improve.

- Trial Initiation: Citryll has commenced its Phase IIa clinical trial for CIT-013 targeting moderate to severe hidradenitis suppurativa in Oss, Netherlands, with the first patient dosed, marking a significant advancement in treating immune-mediated inflammatory diseases.
- Patient Cohort Size: The trial will enroll 96 participants over a 12-week period to assess the efficacy, safety, and tolerability of CIT-013, addressing a critical gap in treatment options currently available for this condition.
- Advisory Board Formation: Citryll has established a Clinical Advisory Board comprising global dermatology experts to provide strategic guidance throughout the trial, enhancing the company’s credibility and expertise in the field.
- Innovative Treatment Mechanism: As the first monoclonal antibody targeting extracellular traps, CIT-013 features a unique dual mechanism of action that may offer more effective treatment options for hidradenitis suppurativa and other inflammatory diseases, positioning the company for long-term growth in the biopharmaceutical sector.






